Celltrion Pharm Inc (068760) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.055x

Based on the latest financial reports, Celltrion Pharm Inc (068760) has a cash flow conversion efficiency ratio of 0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩23.44 Billion ≈ $15.89 Million USD) by net assets (₩426.42 Billion ≈ $288.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Celltrion Pharm Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Celltrion Pharm Inc - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Celltrion Pharm Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Celltrion Pharm Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Celltrion Pharm Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Dogan Sirketler Grubu Holding AS IS:DOHOL	0.116x
Grupo Televisa S.A.B. F:TLV	0.100x
Biotage AB ST:BIOT	0.011x
Treehouse Foods Inc NYSE:THS	0.030x
Sino Medical Sciences Technology In SHG:688108	0.030x
United Corporations Limited TO:UNC	-0.001x
Tourmaline Bio Inc. NASDAQ:TRML	-0.078x
Changzhou Tronly New Electronic Materials Co Ltd SHE:300429	0.043x

Annual Cash Flow Conversion Efficiency for Celltrion Pharm Inc (2014–2024)

The table below shows the annual cash flow conversion efficiency of Celltrion Pharm Inc from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see 068760 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩396.92 Billion ≈ $268.99 Million	₩56.59 Billion ≈ $38.35 Million	0.143x	+513.25%
2023-12-31	₩376.67 Billion ≈ $255.26 Million	₩8.76 Billion ≈ $5.93 Million	0.023x	+305.01%
2022-12-31	₩356.79 Billion ≈ $241.79 Million	₩-4.05 Billion ≈ $-2.74 Million	-0.011x	-104.04%
2021-12-31	₩331.97 Billion ≈ $224.97 Million	₩93.15 Billion ≈ $63.13 Million	0.281x	+132.68%
2020-12-31	₩300.56 Billion ≈ $203.69 Million	₩36.25 Billion ≈ $24.56 Million	0.121x	+21.24%
2019-12-31	₩280.03 Billion ≈ $189.77 Million	₩27.85 Billion ≈ $18.88 Million	0.099x	+87.67%
2018-12-31	₩270.03 Billion ≈ $183.00 Million	₩14.31 Billion ≈ $9.70 Million	0.053x	+253.13%
2017-12-31	₩293.62 Billion ≈ $198.98 Million	₩-10.16 Billion ≈ $-6.89 Million	-0.035x	+21.58%
2016-12-31	₩344.65 Billion ≈ $233.56 Million	₩-15.21 Billion ≈ $-10.31 Million	-0.044x	-178.02%
2015-12-31	₩236.23 Billion ≈ $160.09 Million	₩13.36 Billion ≈ $9.06 Million	0.057x	-29.99%
2014-12-31	₩214.43 Billion ≈ $145.31 Million	₩17.33 Billion ≈ $11.74 Million	0.081x	--

About Celltrion Pharm Inc

KQ:068760 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$1.23 Billion

₩1.82 Trillion KRW

Market Cap Rank

#8171 Global

#216 in Korea

Share Price

₩41900.00

Change (1 day)

-3.23%

52-Week Range

₩40500.00 - ₩75700.00

All Time High

₩222138.48